PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 120 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $530,000 | +72.1% | 22,000 | +37.5% | 0.04% | -8.3% |
| Q1 2017 | $308,000 | +59.6% | 16,000 | +28.0% | 0.05% | +50.0% |
| Q4 2016 | $193,000 | +48.5% | 12,500 | +25.0% | 0.03% | +52.4% |
| Q3 2016 | $130,000 | -6.5% | 10,000 | 0.0% | 0.02% | -12.5% |
| Q2 2016 | $139,000 | -51.2% | 10,000 | -33.3% | 0.02% | -35.1% |
| Q4 2015 | $285,000 | – | 15,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |